Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fielmann Group AGFLMNF 86 Return-on-Tangible-Asset is 12.16% as of Mar. 2026, which is 11% above its 10-year median of 10.97. GuruFocus rates FLMNF with a GF Score™ of 86/100 and a GF Value™ of $66.59. The stock has 2 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 87.73% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Fielmann Group AG's annualizedNet Income for the quarter that ended in Mar. 2026 was $258 Mil. Fielmann Group AG's average total tangible assets for the quarter that ended in Mar. 2026 was $2,118 Mil. Therefore, Fielmann Group AG's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 12.16%.
The historical rank and industry rank for Fielmann Group AG's Return-on-Tangible-Asset or its related term are showing as below:
FLMNF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 7.47 Med: 10.97 Max: 19.76
Current: 12.07
During the past 13 years, Fielmann Group AG's highest Return-on-Tangible-Asset was 19.76%. The lowest was 7.47%. And the median was 10.97%.
FLMNF's Return-on-Tangible-Asset is ranked better than 87.73% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.665
vs FLMNF: 12.07
Fielmann Group AG (OTCPK:FLMNF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Fielmann Group AG Return-on-Tangible-Asset Related Terms
Fielmann Group AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FLMNF vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 12.16% mean?
Fielmann Group AG (FLMNF) has a Return-on-Tangible-Asset of 12.16% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Fielmann Group AG and its competitors. This is 11% above median its historical median of 10.97. Over the past decade, Fielmann Group AG's Return-on-Tangible-Asset has ranged from 7.47 to 19.76. According to the industry distribution chart, Fielmann Group AG ranks #105 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 12.3%.
Is Fielmann Group AG's Return-on-Tangible-Asset too high?
Fielmann Group AG's current Return-on-Tangible-Asset of 12.16% is 11% above median its 10-year median of 10.97. Over the past 10 years, this metric has ranged from a low of 7.47 to a high of 19.76. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.67. Fielmann Group AG's value of 12.16% is 1728.6% above this industry median. Based on the distribution chart, Fielmann Group AG ranks #105 out of 856 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fielmann Group AG has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #105 out of 856 companies for Return-on-Tangible-Asset. This places Fielmann Group AG in the top 12% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.67. Fielmann Group AG's value of 12.16% is 1728.6% above this benchmark. Historically, Fielmann Group AG's own Return-on-Tangible-Asset has ranged from 7.47 to 19.76 over the past decade. While the company's 10-year median is 10.97 vs. the industry median of 0.67, Fielmann Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.67, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current Return-on-Tangible-Asset of 12.16% is 1728.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current Return-on-Tangible-Asset is 12.16%, which is 11% above median its own 10-year median of 10.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (FLMNF) has a current Return-on-Tangible-Asset of 12.16%. The stock's GF Value™ is $66.59, compared to a current price of $50.75 — trading 23.8% below its estimated fair value. The current Return-on-Tangible-Asset is 12.16%, which is 11% above median its 10-year median of 10.97 and 1728.6% above the Medical Devices & Instruments industry median of 0.67. Fielmann Group AG's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Fielmann Group AG (FLMNF), the current Return-on-Tangible-Asset is 12.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (FLMNF) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of $50.75 is trading 23.8% below its estimated GF Value™ of $66.59.
Key valuation signals for FLMNF:
Return-on-Tangible-Asset: 12.16% (11% above median its 10-year median of 10.97)
GF Value™: $66.59 vs. price of $50.75 (23.8% below fair value)
Industry Position: 1728.6% above the Medical Devices & Instruments median (#105 of 856)
No single metric tells the full story. See the FLMNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
86GF Score
Get the complete analysis for FLMNF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FLMNF has been successfully added to your 
